Atlas Trials

Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies

Clinical trial NCT00943319 · COMPLETED

Trial details

NCT number
NCT00943319
Sponsor
University of Chicago
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
LeukemiaLymphomaMyeloma
Start date
2012-03-01
Primary completion
2017-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.